The pan-LAT inhibitor 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), which broadly inhibits LAT1-4, has mainly been used in previous reports, and its tumor growth inhibitory activity has been reported in vitro and in vivo in therapeutic experiments [12,13]. The gene discussed is SLC7A5; the disease is neoplasm.